Alltest rapid lateral flow immunoassays is reliable in diagnosing SARS-CoV-2 infection from 14 days after symptom onset: A prospective single-center study
Felipe Pérez‐García, Ramón Pérez‐Tanoira, Juan Romanyk, Teresa Arroyo, Peña Gómez-Herruz, Juan Cuadros‐González
Topics & Concepts
SerologyMedicineInternal medicineImmunoassayPneumoniaGastroenterologyProspective cohort studyEtiologyAntibodyImmunologySARS-CoV-2 detection and testingSARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research Studies